Vancomycin-resistant enterococci isolation and screening strategies: clinical evidence and cost-effectiveness

Record ID 32014000781
Authors' recommendations: One randomized controlled trial, one non-randomized study, and one economic evaluation were identified regarding either the clinical or cost-effectiveness of patient screening or isolation measures for VRE.
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Mass Screening
  • Vancomycin Resistance
  • Enterococcus
  • Gram-Positive Bacterial Infections
Organisation Name: Canadian Agency for Drugs and Technologies in Health
Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
Contact Email:
Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.